1. Oláhová, Monika, Peter, Bradley, Szilagyi, Zsolt, Gustafsson, Claes M, Taylor, Robert W. 2021. POLRMT mutations impair mitochondrial transcription causing neurological disease. In Nature communications, 12, 1135. doi:10.1038/s41467-021-21279-0. https://pubmed.ncbi.nlm.nih.gov/33602924/
2. Velasco-Ruiz, Alejandro, Nuñez-Torres, Rocio, Pita, Guillermo, Lopez-Fernandez, Teresa, Gonzalez-Neira, Anna. 2021. POLRMT as a Novel Susceptibility Gene for Cardiotoxicity in Epirubicin Treatment of Breast Cancer Patients. In Pharmaceutics, 13, . doi:10.3390/pharmaceutics13111942. https://pubmed.ncbi.nlm.nih.gov/34834357/
3. Bonekamp, Nina A, Peter, Bradley, Hillen, Hauke S, Gustafsson, Claes M, Larsson, Nils-Göran. 2020. Small-molecule inhibitors of human mitochondrial DNA transcription. In Nature, 588, 712-716. doi:10.1038/s41586-020-03048-z. https://pubmed.ncbi.nlm.nih.gov/33328633/
4. Scarpulla, Richard C. . Transcriptional paradigms in mammalian mitochondrial biogenesis and function. In Physiological reviews, 88, 611-38. doi:10.1152/physrev.00025.2007. https://pubmed.ncbi.nlm.nih.gov/18391175/
5. Kühl, Inge, Miranda, Maria, Posse, Viktor, Gustafsson, Claes M, Larsson, Nils-Göran. 2016. POLRMT regulates the switch between replication primer formation and gene expression of mammalian mtDNA. In Science advances, 2, e1600963. doi:10.1126/sciadv.1600963. https://pubmed.ncbi.nlm.nih.gov/27532055/
6. Li, Xiaojun, Yao, Linya, Wang, Tao, Wu, Yufan, Jiang, Ting. 2023. Identification of the mitochondrial protein POLRMT as a potential therapeutic target of prostate cancer. In Cell death & disease, 14, 665. doi:10.1038/s41419-023-06203-2. https://pubmed.ncbi.nlm.nih.gov/37816734/
7. Wang, Hao, Liu, Yuxin, Lu, Xing-Sheng, Gu, Wen, Yin, Guojian. 2024. Targeting POLRMT by IMT1 inhibits colorectal cancer cell growth. In Cell death & disease, 15, 643. doi:10.1038/s41419-024-07023-8. https://pubmed.ncbi.nlm.nih.gov/39227564/
8. Huang, Yongkang, Qian, Yajuan, Xing, Yufei, Zhou, Tong, Shi, Minhua. 2023. POLRMT over-expression is linked to WNT/beta-catenin signaling, immune infiltration, and unfavorable outcomes in lung adenocarcinoma patients. In Cancer medicine, 12, 15691-15703. doi:10.1002/cam4.6174. https://pubmed.ncbi.nlm.nih.gov/37283308/
9. Yu, Hui-Jing, Xiao, Guan-Li, Zhao, Yu-Ying, Wang, Xin-Xin, Lan, Rongfeng. 2021. Targeting Mitochondrial Metabolism and RNA Polymerase POLRMT to Overcome Multidrug Resistance in Cancer. In Frontiers in chemistry, 9, 775226. doi:10.3389/fchem.2021.775226. https://pubmed.ncbi.nlm.nih.gov/34976949/
智鼠故事 
